Department of Radiology, University of Yamanashi, Yamanashi, Japan.
Thorac Cancer. 2023 Dec;14(35):3445-3452. doi: 10.1111/1759-7714.15137. Epub 2023 Oct 16.
The purpose of this study was to compare the dosimetric characteristics of five different treatment planning techniques for locally advanced non-small cell lung cancer (LA-NSCLC) with sequential plan changes.
A total of 13 stage III NSCLC patients were enrolled in this study. These patients had both computed tomography (CT) images for initial and boost treatment plans. The latter CT images were taken if tumor shrinkage was observed after 2 weeks of treatment. The prescription dose was 60 Gy/30 Fr (initial: 40 Gy/20 Fr, and boost: 20 Gy/10 Fr). Five techniques (forward-planed 3-dimensional conformal radiotherapy [F-3DCRT] on both CT images, inverse-planned 3DCRT [I-3DCRT] on both CT images, volumetric modulated arc therapy [VMAT] on both CT images, F-3DCRT on initial CT plus VMAT on boost CT [bVMAT], and hybrid of fixed intensity-modulated radiotherapy [IMRT] beams and VMAT beams on both CT images [hybrid]) were recalculated for all patients. The accumulated doses between initial and boost plans were compared among all treatment techniques.
The conformity indexes (CI) of the planning target volume (PTV) of the five planning techniques were 0.34 ± 0.10, 0.57 ± 0.10, 0.86 ± 0.08, 0.61 ± 0.12, and 0.83 ± 0.11 for F-3DCRT, I-3DCRT, VMAT, bVMAT, and hybrid, respectively. In the same manner, lung volumes receiving >20 Gy (V ) were 21.05 ± 10.56%, 20.86 ± 6.45, 19.50 ± 7.38%, 19.98 ± 10.04%, and 17.74 ± 7.86%. There was significant improvement about CI and V for hybrid compared with F-3DCRT (p < 0.05).
The IMRT/VMAT hybrid technique for LA-NSCLC patients improved target CI and reduced lung doses. Furthermore, if IMRT was not available initially, starting with 3DCRT might be beneficial as demonstrated in the bVMAT procedure of this study.
本研究旨在比较 5 种不同治疗计划技术在局部晚期非小细胞肺癌(LA-NSCLC)序贯计划变更中的剂量学特征。
本研究共纳入 13 例 III 期 NSCLC 患者。这些患者均有初始和推量治疗计划的 CT 图像。如果治疗 2 周后肿瘤缩小,则进行后者 CT 图像。处方剂量为 60 Gy/30 Fr(初始:40 Gy/20 Fr,推量:20 Gy/10 Fr)。对所有患者重新计算了 5 种技术(初始和推量 CT 图像的正向计划三维适形放疗[F-3DCRT]、初始和推量 CT 图像的逆向计划三维适形放疗[I-3DCRT]、初始和推量 CT 图像的容积调强弧形治疗[VMAT]、初始 CT 的 F-3DCRT 加推量 CT 的 VMAT[bVMAT]、初始和推量 CT 图像的固定强度调制放疗[IMRT]束和 VMAT 束的混合[混合])。比较了所有治疗技术之间初始和推量计划之间的累积剂量。
5 种计划技术的计划靶区(PTV)的适形指数(CI)分别为 0.34±0.10、0.57±0.10、0.86±0.08、0.61±0.12 和 0.83±0.11,F-3DCRT、I-3DCRT、VMAT、bVMAT 和混合。同样,肺接受>20 Gy(V)的体积分别为 21.05±10.56%、20.86±6.45%、19.50±7.38%、19.98±10.04%和 17.74±7.86%。与 F-3DCRT 相比,混合技术的 CI 和 V 有显著改善(p<0.05)。
LA-NSCLC 患者的 IMRT/VMAT 混合技术提高了靶区 CI,降低了肺剂量。此外,如果最初没有使用 IMRT,本研究中 bVMAT 程序表明,从 3DCRT 开始可能是有益的。